Havana, Cuba

Teresita Rodriguez Obaya

This inventor holds 1 USPTO granted patent. Top assignee: Centro De Immunologia Molecular (Cim). Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Teresita Rodriguez Obaya. Retrieved from https://idiyas.com/inventor/teresita-rodriguez-obaya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Teresita Rodriguez Obaya: Innovator in Monoclonal Antibodies

Introduction

Teresita Rodriguez Obaya is a distinguished inventor based in Habana, Cuba. He has made significant contributions to the field of immunology, particularly in the development of monoclonal antibodies. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

Teresita holds a patent for "Monoclonal anti-idiotypic antibodies (AB2) and their uses." This patent represents a crucial advancement in the understanding and application of monoclonal antibodies, which are vital in therapeutic and diagnostic processes.

Career Highlights

He is affiliated with the Centro de Inmunología Molecular, where he has been instrumental in research and development. His career reflects a commitment to advancing medical science through innovative solutions.

Collaborations

Teresita has collaborated with notable colleagues, including Amparo Emilia Macias Abrahan and Rolando Perez Rodriguez. These partnerships have fostered a collaborative environment that enhances research outcomes.

Conclusion

Teresita Rodriguez Obaya's contributions to the field of immunology through his patent and collaborative efforts highlight the vital role of inventors in advancing medical science. His work continues to inspire future innovations in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…